Last reviewed · How we verify
Kaletra soft-gel capsules switched to Kaletra tablets
Kaletra soft-gel capsules switched to Kaletra tablets is a Small molecule drug developed by AIDS Arms Inc.. It is currently FDA-approved.
At a glance
| Generic name | Kaletra soft-gel capsules switched to Kaletra tablets |
|---|---|
| Sponsor | AIDS Arms Inc. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Comparison Study of Kaletra Soft-Gel Capsules and Kaletra Tablets in an African American Cohort (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Kaletra soft-gel capsules switched to Kaletra tablets CI brief — competitive landscape report
- Kaletra soft-gel capsules switched to Kaletra tablets updates RSS · CI watch RSS
- AIDS Arms Inc. portfolio CI
Frequently asked questions about Kaletra soft-gel capsules switched to Kaletra tablets
What is Kaletra soft-gel capsules switched to Kaletra tablets?
Kaletra soft-gel capsules switched to Kaletra tablets is a Small molecule drug developed by AIDS Arms Inc..
Who makes Kaletra soft-gel capsules switched to Kaletra tablets?
Kaletra soft-gel capsules switched to Kaletra tablets is developed and marketed by AIDS Arms Inc. (see full AIDS Arms Inc. pipeline at /company/aids-arms-inc).
What development phase is Kaletra soft-gel capsules switched to Kaletra tablets in?
Kaletra soft-gel capsules switched to Kaletra tablets is FDA-approved (marketed).